Wednesday 15th October 2008 |
Text too small? |
The company will take a one-time provision against its so-called old ledger, which is loans to people with lower credit quality, of NZ$6.3 million in the year ending March 31. As a result, it will post a loss of NZ$4.4 million, compared to the NZ$2.7 million envisaged in its capital reconstruction offer document.
Geneva's banker is BOS International, a unit of the U.K.'s HBOS, which is about to have the British government as a shareholder. A spokesman for BOS in New Zealand declined to comment and a spokesman in Perth couldn't immediately be reached.
Borrowers on the old ledger had been squeezed by rising food and petrol prices, eating into their disposable incomes and increasing defaults, Geneva said. At the same time the global credit squeeze had driven up costs and reduced availability of funds.
"Over the last six months there has been an unprecedented upheaval in the world and the New Zealand economy," Geneva said in a statement. "These events and the related credit impact have had a significant impact on the collectability of the old ledger."
Geneva is in talks with BOS International, after breaching covenants of its financing facility as at Sept. 30. BOS also is involved with the management buyout of Strategic Finance from Allco Hit, which today said that deal has come off the rails and the parties will resume talks.
Excluding the one-time charge, earnings this year would be NZ$1.9 million, Geneva said.
Geneva posted a NZ$7.9 million loss in the 12 months ended March 31, 2008, reflecting the network closure, restructuring costs associated with its moratorium and charges to adopt IFRS accounting.
Geneva has divided its loan book in two, with the new ledger comprising people with better credit records. As at Sept. 30, old ledger loans were NZ$43.7 million, or 43% of the total.
The company has a moratorium on some NZ$138 million of deposits.
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report